加强心房颤动患者的卒中预防
摘要
心房颤动（房颤）是临床实践中最为常见的心律失常之一。调查数据显示，美国成年人群中房颤患病率约1％．80岁以上的高龄老年人群中患病率为10％。我国30～85岁居民中房颤患病率为0．77％，其中80岁以上人群中患病率达30％。
出处
《内科理论与实践》
2011年第6期412-415,共4页
Journal of Internal Medicine Concepts & Practice
参考文献11
-
1Zhou ZQ,Hu DY,Chen J,et al.An epidemiological survey of atrial fibrillation in China[J].Zhonghua Nei Ke Za Zhi,2004,43(7):491-494.
-
2Mant J,Hobbs FD,Fletcher K,et al.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation(the Birmingham atrial fibrillation treatment of the aged study,BAFTA):a randomised controlled trial[J].Lancet,2007,370(9586):493-503.
-
3Connolly S,Pogue J,Hart R,et al.Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events(ACTIVE W):a randomised controlled trial[J].Lancet,2006,367(9526):1903-1912.
-
4Pérez-Gómez F,Alegría E,Berjón J,et al.Comparative effects of antiplatelet,anticoagulant,or combined therapy in patients with valvular and nonvalvular atrial fibrillation:a randomized multicenter study[J].J Am Coll Cardiol,2004,44(8):1557-1566.
-
5Hart RG,Pearce LA,Aguilar MI.Meta-analysis:antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J].Ann Intern Med,2007,146(12):857-867.
-
6Patel MR,Mahaffey KW,Garg J,et al.Rivaroxaban versus warfarin in nonvalvular atrial fibrillation[J].N Engl J Med,2011,365(10):883-891.
-
7Connolly SJ,Eikelboom J,Joyner C,et al.Apixaban in patients with atrial fibrillation[J].N Engl J Med,2011,364(9):806-817.
-
8Granger CB,Alexander JH,McMurray JJ,et al.Apixaban versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2011,365(11):981-992.
-
9Connolly SJ,Ezekowitz MD,Yusuf S,et al.Dabigatran versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2009,361(12):1139-1151.
-
10Legrand M,Mateo J,Aribaud A,et al.The use of dabigatran in elderly patients[J].Arch Intem Med,2011,171(14):1285-1286.
-
1胡发明,过鑫昌.房颤病人的卒中预防[J].国外医药（合成药．生化药．制剂分册）,2001,22(4):218-218.
-
2范书平,张国平,张宏力,程丽容,甄素平,张建容,吴静.心房颤动诱因及卒中预防——附130例临床观察[J].实用心脑肺血管病杂志,2007,15(9):693-694.
-
3杨远程.别再让焦虑折磨你[J].家庭健康（医学科普）,2010(6):12-12.
-
4赵军红.探究房颤患者卒中预防的重要性[J].世界最新医学信息文摘,2015,15(62).
-
5董可辉.贯彻分层理念,发挥他汀的卒中预防优势[J].中国社区医师,2009,25(4):11-12. 被引量：2
-
6沈洁玲,张新江,陶丽红,唐铁钰.心房颤动患者卒中预防中的抗凝治疗：安全性和依从性[J].国际脑血管病杂志,2016,24(1):68-74. 被引量：3
-
7陈孝东,王光胜,曹勇军.糖尿病及代谢综合征患者的卒中预防[J].中华神经医学杂志,2009,8(6):643-645. 被引量：2
-
8魏东宁.脑静脉血栓形成[J].中华脑血管病杂志（电子版）,2008,2(1):32-38. 被引量：4
-
9林豪杰,汪昕.他汀类药物在卒中预防中的循证医学证据[J].中华内科杂志,2007,46(3):252-253. 被引量：1
-
10陈志坚,易桂文.2016年ESC心房颤动管理指南更新解读[J].临床心血管病杂志,2016,32(11):1076-1078. 被引量：49
